TissGeneSummary for EDC3 |
Gene summary |
Basic gene information | Gene symbol | EDC3 |
Gene name | enhancer of mRNA decapping 3 | |
Synonyms | LSM16|YJDC|YJEFN2 | |
Cytomap | UCSC genome browser: 15q24.1 | |
Type of gene | protein-coding | |
RefGenes | NM_001142443.1, NM_001142444.1,NM_025083.3, | |
Description | LSM16 homolog (EDC3, S. cerevisiae)enhancer of mRNA decapping 3 homologenhancer of mRNA-decapping protein 3hYjeF_N2hYjeF_N2-15q23yjeF N-terminal domain-containing protein 2yjeF domain containingyjeF domain-containing protein 1yjeF_N2 | |
Modification date | 20141207 | |
dbXrefs | MIM : 609842 | |
HGNC : HGNC | ||
Ensembl : ENSG00000179151 | ||
HPRD : 07954 | ||
Vega : OTTHUMG00000142815 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_EDC3 | |
BioGPS: 80153 | ||
Pathway | NCI Pathway Interaction Database: EDC3 | |
KEGG: EDC3 | ||
REACTOME: EDC3 | ||
Pathway Commons: EDC3 | ||
Context | iHOP: EDC3 | |
ligand binding site mutation search in PubMed: EDC3 | ||
UCL Cancer Institute: EDC3 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | ProstateTestis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | PRADTGCT | |
Reference showing the relevant tissue of EDC3 | ||
Description by TissGene annotations | Have significant anti-correlated miRNA TissgsLTS |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for EDC3 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
Top |
TissGene-miRNA for EDC3 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
UCS | hsa-miR-653-5p | MIMAT0003328 | 0.048 | -0.27 | 56 |
LUAD | hsa-miR-22-3p | MIMAT0000077 | 0.0023 | -0.39 | 60 |
Top |
TissGeneMut for EDC3 |
TissGeneSNV for EDC3 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.S161F | SKCM | 1 |
p.S131F | SKCM | 1 |
p.Q133R | STAD | 1 |
p.G468W | GBM | 1 |
p.R24S | THYM | 1 |
p.G90D | STAD | 1 |
p.E147K | SKCM | 1 |
p.S138* | BLCA | 1 |
p.P237R | STAD | 1 |
p.T34I | SKCM | 1 |
p.E248K | HNSC | 1 |
p.Q115E | CESC | 1 |
p.E83X | COAD | 1 |
p.V407A | KIRP | 1 |
p.R303Q | SARC | 1 |
p.P174L | SKCM | 1 |
p.I222V | BRCA | 1 |
p.V404E | KIRC | 1 |
p.R232H | PRAD | 1 |
p.D454G | UCEC | 1 |
p.K63N | READ | 1 |
p.G208R | CESC | 1 |
p.H168Y | PAAD | 1 |
p.Y284H | LIHC | 1 |
p.I474M | ESCA | 1 |
p.S394F | BLCA | 1 |
p.C14Y | LIHC | 1 |
p.E469K | ESCA | 1 |
p.P68S | SKCM | 1 |
p.D122A | BLCA | 1 |
Top |
TissGeneCNV for EDC3 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for EDC3 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | BE095213 | EDC3-EDC3 | chr15:74925601 | chr15:74925607 | |
TCGAfusionPortal | PRADA | BRCA | TCGA-B6-A0IM-01A | EDC3-SNX29 | 5UTR-CDS | Chr15:74988221 | Chr16:12293458 |
Top |
TissGeneNet for EDC3 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for EDC3 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for EDC3 |
TissGeneDrug for EDC3 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for EDC3 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C3714756 | Intellectual Disability | 1 | BeFree |